Tirzepatide Raws Powder CAS{0}}% Purity Min
Lub npe Askiv: Tirzepatide
CAS Nr .: 2023788-19-2
Molecular Luj: 4813.58g/mol
Molecular Formula: C₂₂₁H₃4₉N₆₅O₇₁S
Qhov tsos: dawb hmoov
tsw: no
Stability: ruaj khov
MSDS thiab COA: muaj rau koj siv
Peev xwm: 500g ib hlis
Qhov tsos: dawb hmoov
Source: hluavtaws
Purity (HPLC) >98.0%
Qhov chaw ntawm Keeb Kwm: Tuam Tshoj Yinherb-Lab
Packing: Raws li tus neeg siv khoom xav tau
Yam tsawg kawg nkaus Order Quantity: 10g
Cia: Khaws rau hauv qhov chaw txias & qhuav, Khaws kom deb ntawm lub teeb muaj zog thiab cua sov rau 2 xyoos
Hauj lwm lawm
Xi'an Yinherb Bio-Tech Co., Ltd. yog ib qho ntawm cov ua lag luam thiab cov chaw muag khoom ntawm tirzepatide raw hmoov cas.2023788-19-2 98% purity min hauv Suav teb, kuj txhawb kev pabcuam customized. Txais tos mus yuav tej tirzepatide raws hmoov cas.2023788-19-2 98% purity min rau muag ntawm no los ntawm peb lub hoobkas. Cov khoom zoo thiab tus nqi tsim nyog muaj.

Kev Tshawb Fawb Kev Tshawb Fawb ntawm Nootropics & peptide hauv Suav teb
Yinherb Lab yog lub chaw tshawb fawb kev tshaj lij hauv Suav teb, tau tsom mus rau Cov Khoom Noj Khoom Haus, Nootropics thiab Peptide raw cov ntaub ntawv tshawb fawb thiab tsim tawm hauv kev lag luam no rau ntau tshaj 10 xyoo nrog kev ruaj khov zoo thiab muaj koob npe nrov, peb tuaj yeem muab txhua qhov kev xeem batch, suav nrog COA, HPLC thiab NMR. Kuv ntseeg tias peb yuav tsum ua haujlwm zoo yav tom ntej.
Yinherb Lab High Quality Tirzepatide Raws hmoov CAS{0}}% Purity Min
|
Khoom npe: |
Tirzepatide | |
| Chemical Class | Dual GIP / GLP-1 Receptor Agonist (Synthetic Peptide) | Pharmacological Assay |
| Amino Acid Sequence | H-Ala-Gly-Thr-Ph-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu{{12}Glu{12}Glu{1} }}Ala-Ala-Lys-Glu-Ph-Ile-Ala- Trp-Leu-Val-Lys-Gly-Arg-Gly-OH (39 amino acids) | Edman Degradation / Mass Spectrometry (MS) |
| Molecular Formula | C₂₂₁H₃4₉N₆₅O₇₁S | Elemental Analysis & NMR |
| Molecular Luj | 4813.58 g / mol (tus nqi theoretical) | Electrospray Ionization Mass Spectrometry (ESI{0}}MS) |
| Qhov tshwm sim | Dawb kom tawm -dawb, dawb- ntws lyophilized hmoov; tsw tsw | Kev soj ntsuam pom pom & Olfactory (USP<191>) |
| Purity (HPLC) | Ntau dua lossis sib npaug li 99.0% (API Qib); Yam Khoom Muaj Tsawg dua lossis sib npaug li 1.0% | RP-HPLC (USP<621>, Kem: C18, Txawb Phase: Acetonitrile-Dej-Trifluoroacetic Acid) |
| Solubility | Soluble hauv dej (Ntau dua lossis sib npaug ntawm 20 mg / mL, 25 degree); me ntsis soluble hauv ethanol; insoluble nyob rau hauv non-polar solvents | Gravimetric Solubility Test (EP 2.2.10) |
| Isoelectric Point (pI) | 8.5–9.0 | Isoelectric Focusing Electrophoresis |
| Kev ua lom lom | EC₅₀ rau GIP Receptor: Tsawg dua lossis sib npaug rau 0.5 nM; EC₅₀ rau GLP-1 Receptor: Tsawg dua lossis sib npaug rau 0.3 nM | Cell -Raws li Kev Ntsuas Ua Haujlwm (cAMP Detection) |
| Poob rau ziab | Tsawg dua lossis sib npaug li 2.0% | Nqus Qhuav ntawm 60℃rau 3h (USP<731>) |
| Hnyav Hlau | Tag nrho cov hlau hnyav tsawg dua lossis sib npaug li 5 ppm; Lead (Pb) Tsawg dua lossis sib npaug li 1 ppm; Cadmium (Cd) Tsawg dua lossis sib npaug li 0.1 ppm | ICP-MS (USP<233>) |
| Endotoxin Cov ntsiab lus | Tsawg dua lossis sib npaug li 0.5 EU / mg | Limulus Amebocyte Lysate (LAL) Test (USP<85>) |
| Microbial txwv | Tag nrho Aerobic Microbial suav Tsawg dua lossis sib npaug rau 10 CFU / g; Pwm & Pwm Tsawg dua lossis sib npaug li 5 CFU / g; Cov kab mob (E. coli, Salmonella) Tsis zoo | USP<61> & <62> |
Tirzepatide raws hmoov yog dab tsi?
Tirzepatide yog ib qho tshiab, FDA- pom zoodual qabzib-dependent insulinotropic polypeptide (GIP) thiab glucagon-zoo li peptide-1 (GLP-1) receptor agonisttsim los rau kev kho mob ntawm hom 2 mob ntshav qab zib mellitus thiab tswj qhov hnyav hnyav. Raws li cov tshuaj peptide hluavtaws, nws nthuav tawm cov qabzib zoo dua - txo qis thiab qhov hnyav - txo cov txiaj ntsig piv rau ib leeg - lub hom phiaj GLP-1 agonists, ua rau nws yog ib qho tseem ceeb ntawm cov khoom siv tshuaj (API) hauv lub khw muag tshuaj thoob ntiaj teb.
Tirzepatide yog linear polypeptide uas muaj 39 amino acids, nrog rau cov qauv tshwj xeeb uas ua rau tib lub sijhawm ua haujlwm ntawm GIP thiab GLP-1 receptors-ob qhov tseem ceeb incretin cov tshuaj hormones koom nrog hauv cov piam thaj metabolism thiab kev noj qab haus huv cov cai. Nws yog feem ntau muab raws li ib tugdawb kom tawm -dawb lyophilized hmoov(rau kev txhaj tshuaj formulation) nrog siab purity thiab lom lom.


Tirzepatide Raws Powder Mechanism of Action and Additional Efficacy
Pharmacological Mechanisms
Dual Receptor Activation: Ib txhij khi rau thiab qhib GIP thiab GLP-1 receptors hauv cov txiav, plab hnyuv, thiab hauv nruab nrab paj hlwb. Qhov no synergistically nkoos insulin secretion (glucose-dependent), inhibits glucagon tso, slows plab hnyuv plab, thiab txo cov zaub mov noj.
Ntev Ib nrab -Lub Neej: Cov qauv hloov kho kom tiv thaiv kev degradation los ntawm dipeptidyl peptidase 4 (DPP-4), txuas nws ib nrab- lub neej mus rau ~ 5 hnub hauv tib neeg, ua kom muaj kev tswj hwm ib lub lim tiam (qhov zoo dua li niaj hnub GLP-1 agonists).
Kev cai Metabolic: Tshaj li kev tswj hwm cov piam thaj, nws txo lub cev hnyav los ntawm kev txo qis qab los noj mov thiab nce kev siv zog, thiab qhia tau tias muaj peev xwm txhim kho lipid profile thiab txo cov kev pheej hmoo ntawm cov hlab plawv.

Tirzepatide Raws Powder Application Scenarios thiab Kev Siv Yuav Tsum Tau
Hom 2 mob ntshav qab zib mellitus (T2DM): Pom zoo ua thawj zaug - kab kev kho rau T2DM los txhim kho glycemic tswj hauv cov neeg laus, xws li monotherapy lossis ua ke nrog lwm cov tshuaj tiv thaiv kab mob (xws li metformin).
Kev tswj qhov hnyav: FDA- pom zoo rau kev poob phaus thiab kev saib xyuas qhov hnyav hauv cov neeg laus uas rog rog lossis rog dhau thiab tsawg kawg ib qho hnyav - cuam tshuam txog kev sib txuam (xws li, kub siab, dyslipidemia).
Pharmaceutical Formulation: Siv los tsim cov tshuaj txhaj tshuaj (ua ntej- cov cwj mem puv) nrog cov khoom siv xws li mannitol, sodium phosphate, thiab dej rau kev txhaj tshuaj, ua raws li GMP cov qauv rau cov khoom siv tshuaj tsis muaj menyuam.

Tirzepatide Raws Powder Storage Conditions
Ntim Specifications: Lyophilized hmoov ntim rau hauv 1g / vial, 5g / vial, lossis 10g / vial (amber iav vials nrog roj hmab stoppers thiab txhuas crimp seals) los tiv thaiv lub teeb thiab noo noo. Ntim ntim rau kev lag luam siv: 100g / nruas (txhuas-kab HDPE nruas).
Kev cia khoom: Khw ntawm-20℃± 5 degreenyob rau hauv ib lub thawv ntim, lub teeb - tiv thaiv; zam rov qab khov -thaw cycles. Txee lub neej: 24 lub hlis raws li kev pom zoo khaws cia (validated ntawm ICH Q1A stability test).
Cov khoom lag luam ntsig txog
Tshwj xeeb hauv Semaglutide, Tirzepatide, Retatrutide, DSIP, Eptalone, Selank, Semax, Melanotan II, Thymosin alpha 1, Oxytocin, P21, Adamax, Dihexa thiab tus tub ntawm.
![]() |
![]() |
Cov ntawv pov thawj

FDA

Halal

ISO 9001 Cov

Kosher

Kev Tshawb Fawb Tshaj Tawm

SGS
Yinherb Lab nrhiav tau nyob rau hauv 2009, tau mob siab rau rau biotechnology teb rau ntau tshaj kaum xyoo. Niaj hnub no, nws tau tsim ib qho kev txhim kho kev ua haujlwm nrog "R & D + ntau lawm" ua ib qho kev sib koom ua ke. Thiab ib txwm ua raws li cov kev lag luam tseem ceeb ntawm "Quality First, Service Second, Price Third".
Peb qhov chaw nyob
No.3, Daqing rd, Hi-tech zone, Xi'an, Suav teb.
Xov tooj
+8618681897250
E -mail

Cim npe nrov: tirzepatide raws hmoov cas.2023788-19-2 98% purity min, Tuam Tshoj tirzepatide raws hmoov cas.2023788-19-2 98% purity min manufacturers, lwm tus neeg, Hoobkas
Xa kev nug
Koj Tseem Yuav Zoo Li
-

Epitalon Peptide Powder CAS .307297-39-8 98% Purity Min
-

Selank Powder CAS.129954-34-3 98% Purity Min
-

Glyx 13 Peptide CAS . 117928-94-6 99% Purity Min
-

Cagrilinitide Powder CAS . 1415456-99-3 99% Purity Min
-

Thymulin Acetate Powder CAS . 63958-90-7 99% Purity Min
-

Eptifibatide Powder CAS . 188627-80-7 99% Purity Min











